Toficalm 100mg Tablets
Toficalm 100 is an anti-anxiety medication formulated with Tofisopam 100 mg, a 2,3-benzodiazepine derivative designed for daytime management of anxiety, tension, and mood disorders. Unlike conventional sedative agents, Toficalm enhances the calming effects of GABA in the brain without causing muscle relaxation, drowsiness, or cognitive impairment.Primary UsesGeneralized Anxiety Disorder (GAD)Psych
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
Toficalm 100 is an anti-anxiety medication formulated with Tofisopam 100 mg, a 2,3-benzodiazepine derivative designed for daytime management of anxiety, tension, and mood disorders. Unlike conventional sedative agents, Toficalm enhances the calming effects of GABA in the brain without causing muscle relaxation, drowsiness, or cognitive impairment.
Primary Uses
- Generalized Anxiety Disorder (GAD)
- Psychosomatic symptoms and stress-induced physical discomfort
- Mood swings and irritability
- Adjunct support for mild to moderate depression
- Supportive care during alcohol withdrawal
Key Characteristics & Benefits
- Non-Sedating Formula: Provides daytime anxiety relief while preserving focus, memory, and mental clarity.
- Low Dependency Profile: Designed to offer anxiolytic effects with a lower risk of sedation or dependency compared to classic benzodiazepines.
- Rapid Action: Typically provides noticeable relief within 1 to 2 hours of administration.
Administration & Storage
Swallow tablets whole with water, with or without food, as directed by a healthcare professional. Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
| Brand | Toficalm |
| Active Ingredient | Tofisopam |
| Strength | 100 mg |
| Drug Class | 2,3-Benzodiazepine |
| Form | Tablet |
| Manufacturer | Sun Pharma |
| Packaging | 10 Tablet in 1 Strip |
| Administration Route | Oral |
| pack size | 100 Pills, 200 Pills, 300 Pills |
|---|---|
| Brand | Toficalm |








Reviews
There are no reviews yet.